NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,145.00
+65.00 (3.13%)
At close: Mar 12, 2026

NGeneBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21
56,01832,41171,664116,027201,381
Market Cap Growth
66.86%-54.77%-38.23%-42.38%-
Enterprise Value
66,29840,75456,79789,239-
Last Close Price
2145.001642.004897.308173.9214269.12
PS Ratio
5.615.7016.4710.5328.11
PB Ratio
3.541.834.414.585.92
P/TBV Ratio
5.203.544.974.916.23
EV/Sales Ratio
6.647.1613.058.10-
Debt / Equity Ratio
1.050.510.710.450.21
Net Debt / Equity Ratio
0.670.09-0.68-0.93-0.50
Net Debt / EBITDA Ratio
-1.00-0.120.913.202.22
Net Debt / FCF Ratio
-1.19-0.121.152.651.62
Asset Turnover
0.260.150.090.22-
Inventory Turnover
4.421.911.933.29-
Quick Ratio
0.790.660.981.253.22
Current Ratio
0.930.931.141.493.40
Return on Equity (ROE)
-108.49%-82.15%-61.88%-33.17%-
Return on Assets (ROA)
-21.45%-26.71%-17.05%-10.75%-
Return on Capital Employed (ROCE)
-77.10%-78.70%-72.70%-31.70%-24.40%
Earnings Yield
-23.13%-38.96%-17.82%-8.43%-4.19%
FCF Yield
-15.82%-38.77%-13.33%-7.63%-5.24%
Buyback Yield / Dilution
-60.90%-31.30%-1.66%-0.89%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.